Pages that link to "Q37096344"
Jump to navigation
Jump to search
The following pages link to The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy (Q37096344):
Displaying 50 items.
- Autoantibodies in primary sclerosing cholangitis (Q27489093) (← links)
- Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies (Q31170968) (← links)
- Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity? (Q33707602) (← links)
- Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis (Q34287861) (← links)
- Current status of therapy in autoimmune liver disease (Q34408950) (← links)
- Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis (Q34479345) (← links)
- Risk factors for hilar cholangiocarcinoma: a case-control study in China (Q34487230) (← links)
- Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches (Q34623557) (← links)
- Characterization of animal models for primary sclerosing cholangitis (PSC). (Q35896870) (← links)
- Management of primary sclerosing cholangitis: conventions and controversies (Q35962107) (← links)
- Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis (Q36151669) (← links)
- Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis (Q36770528) (← links)
- Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis (Q37206473) (← links)
- Preneoplastic conditions underlying bile duct cancer (Q37246190) (← links)
- Endoscopic and surgical management of primary sclerosing cholangitis. (Q37355773) (← links)
- The immunopathology of human biliary cell epithelium (Q37521970) (← links)
- Hepatobiliary associations with inflammatory bowel disease (Q37636108) (← links)
- Anti-fibrotic therapy: lost in translation? (Q37980899) (← links)
- Non-IBD immunological diseases are a risk factor for reduced survival in PSC. (Q38060237) (← links)
- Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection (Q38127390) (← links)
- Pancreatitis in cats: is it acute, is it chronic, is it significant? (Q38209174) (← links)
- Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion. (Q38219784) (← links)
- Animal models in primary biliary cirrhosis and primary sclerosing cholangitis (Q38244716) (← links)
- ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A. (Q38717030) (← links)
- No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan (Q39012301) (← links)
- Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis (Q39177947) (← links)
- Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders (Q39286331) (← links)
- Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis (Q39775602) (← links)
- Impact of Concurrent Non-IBD Immunological Diseases on the Outcome of Primary Sclerosing Cholangitis (Q39942636) (← links)
- Adult langerhans cell histiocytosis with hepatic and pulmonary involvement (Q40249899) (← links)
- Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients (Q40638450) (← links)
- Coexistence of primary sclerosing cholangitis in a patient with myasthenia gravis (Q40824705) (← links)
- A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin (Q41303036) (← links)
- A Gentleman with Anemia and Cholestasis (Q41608266) (← links)
- Role of the microbiota and antibiotics in primary sclerosing cholangitis (Q42174395) (← links)
- Multisystem Langerhans cell histiocytosis with liver dysfunction as the first presentation: A case report (Q42180614) (← links)
- Recurrence and rejection in liver transplantation for primary sclerosing cholangitis (Q43046283) (← links)
- Patient selection and indications for liver transplantation (Q44705863) (← links)
- Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model (Q45895068) (← links)
- Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. (Q45971399) (← links)
- [Liver transplantation: indications and results]. (Q46040008) (← links)
- Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation. (Q48222619) (← links)
- Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis (Q48283681) (← links)
- Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. (Q48331749) (← links)
- Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC). (Q51002172) (← links)
- Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test (Q51070197) (← links)
- Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden (Q51149276) (← links)
- Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis. (Q52670887) (← links)
- Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease (Q53398244) (← links)
- Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease? (Q54939025) (← links)